Assessment of vaginal health before and after treatment with vaginal suppository containing Lactiplantibacillus pentosus KCA1

Ijeoma Ngozi  Ebenebe; Uduma Eke  Osonwa; Chidimma Ruth  Chukwunwejim; Ugonna Chinwe  Morikwe; Joy Ogugua  Igwe; Charles O  Esimone; Kingsley C  Anukam

doi:10.30574/gscbps.2021.17.1.0302

Authors

Ijeoma Ngozi Ebenebe Department of Pharmaceutical Microbiology and Biotechnology, Faculty of Pharmaceutical Sciences, Nnamdi Azikiwe University, Awka, Anambra State, Nigeria.
Uduma Eke Osonwa Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmaceutical Sciences, Nnamdi Azikiwe University, Awka, Nnewi Campus, Anambra State, Nigeria.
Chidimma Ruth Chukwunwejim Department of Pharmaceutical Microbiology and Biotechnology, Faculty of Pharmaceutical Sciences, Nnamdi Azikiwe University, Awka, Anambra State, Nigeria.
Ugonna Chinwe Morikwe Department of Pharmaceutical Microbiology and Biotechnology, Faculty of Pharmaceutical Sciences, Nnamdi Azikiwe University, Awka, Anambra State, Nigeria.
Joy Ogugua Igwe Department of Pharmaceutical Microbiology and Biotechnology, Faculty of Pharmaceutical Sciences, Nnamdi Azikiwe University, Awka, Anambra State, Nigeria.
Charles O Esimone Department of Pharmaceutical Microbiology and Biotechnology, Faculty of Pharmaceutical Sciences, Nnamdi Azikiwe University, Awka, Anambra State, Nigeria.
Kingsley C Anukam Uzobiogene Genomics, London, Ontario, Canada. ORCID iD: 0000-0002-4074-2258

DOI:

https://doi.org/10.30574/gscbps.2021.17.1.0302

Keywords:

Bacterial Vaginosis, Burden, Reproductive, Participant, Lactiplantibacillus pentosus KCA1, Vaginal Suppository

Abstract

Bacterial Vaginosis (BV) is a polymicrobial syndrome characterized by a shift in the vaginal flora from a predominant population of Lactobacilli to a replacement with anaerobes. Vaginal suppositories containing L. pentosus KCA1 were formulated using glycerol-gelatin base. A prospective and follow-up community-based study was done. Vaginal samples were collected from women of reproductive age (non-pregnant) between 18-45 years. A total of 360 women both symptomatic and asymptomatic provided High Vaginal Swabs (HVS) for BV screening using Nugent scoring method and 65 (18.1 %) participants were identified as having BV by microscopy with 45 (12.5 %) of them being consistent with BV (Nugent score of 7-10) and twenty (5.56 %) being intermediate with BV (Nugent score of 4-6). A baseline and intervention questionnaire were administered to the participants. Majority (81.5 %) of the participants affirmed that they have not heard about BV. Social burden reveals that 90.8 % affirmed that they feel frustrated, having BV symptoms recur after treatment and 83.1 % admitted that BV symptoms makes them feel embarrassed, ashamed and dirty. Majority (58.8 %) claimed that the state of their reproductive health is ‘very good’ four weeks after treatment, while 88.2 % of the participants rated their reproductive health after four weeks of treatment to be ‘somewhat better than now than a year ago’. In conclusion, it was revealed that BV has impact on the social status and quality of life of the participants except on their economic status. Knowledge on the awareness of BV among women of reproductive age is essential.

Metrics

Metrics Loading ...

References

Holzman C, Levnthal J, Jones NM, Wang J. Factors linked to bacterial vaginosis in non-pregnant women. American Journal of Public Health. 2001; 91(10): 1664-1670.

Hay PE. Polybacterial Diseases: Bacterial vaginosis as a mixed infection. In: Brogden K.A., Guthmiller J.M. (Editors). Polymicrobial Diseases. Washington (DC): ASM Press. Part III, Chapter 7, 2002.

Easmon C, Hay P, Ison C. Bacterial vaginosis: A diagnostic approach. Journal Genitourinary Medicine. 1992; 68(2): 134-138.

Begum N, Muazzam S, Shamsuzzaman A, Chowdhury A, Rashid and Islam D. Diagnosis of Bacterial Vaginosis by Acridine Orange staining and its comparison to conventional methods and association of Gardnerella vaginalis with Bacterial Vaginosis. Bangladesh Journal of Medical Microbiology. 2010; 4(1): 37-42.

Klebanoff MA, Schwebke JA, Zhang Y, Nandel TR, Yu KF, Andrews WW. Vulvovaginal symptoms in women with Bacterial Vaginosis. Journal of Obstetrics and Gynecology. 2004; 104: 267-272.

Center for Disease Control (CDC). Sexually Transmitted Diseases Treatment guidelines. 2010; Volume 59(RR-12): 1-116.

Bump and Buesching Bacterial Vaginosis in virginal and sexually active adolescent females: evidence against exclusive sexual transmission. American Journal of Obstetrics and Gynecology. 1988; 158(4): 935-939.

Blackwell AL, Thomas PD, Wareham K, Emery SJ. Health gains from screening for infection of the lower genital tract in women attending for termination of pregnancy. Lancet. 1993; 342: 206–210.

Ralph SG, Rutherford AJ. Wilson JD. Influence of Bacterial Vaginosis on conception and miscarriage in the first trimester: cohort study. British Medical Journal. 1999; (319): 220-223.

McGregor JA, French JI, Parker R, Draper D, Patterson E, Jones W, Thorsgard K, McFee J. Prevention of premature birth by screening and treatment for common genital tract infections: results of a prospective controlled evaluation. American Journal of Obstetrics and Gynaecology. 1995; 173: 157–167.

Anukam K, Reid G. Organisms with Bacterial Vaginosis in Nigeria women as determined by PCR-DGGE and 16s RNA gene sequence. Journal of African Health Science. 2007; 7(2): 69-73.

Adinma JI, Okwoli RN, Agbai AO, Unaeze NC. Gardnerella vaginalis vaginosis in Nigerian Igbo women. Tropical Journal of Obstetrics and Gynecology. 2000; 17(1): 21-23.

Ness RB, Hiller SL, Ritcher HE, Soper DE, Stamm C. Douching in relation to Bacterial Vaginosis, Lactobacilli, Facultative Bacteria in the vagina. American Journal of Obstetrics and Gynecology. 2002; 100: 765-772.

Versteraelen H, Verhelst R, Vaneechoutte M, Temmerman M. The epidemiology of bacterial vaginosis in relation to sexual behaviour. BMC Infectious Diseases. 2010; 10: 81.

Bilardi JE, Walker S, Temple-Smith M, McNair R, Mooney-Somers J, Bellhouse C. The burden of bacterial vaginosis: Women’s’ experience of the physical, emotional, sexual and social impact of living with recurrent bacterial vaginosis. 2013; PLoS One. 8.

Li XD, Wang CC, Zhang XJ, Gao GP, Tong F, Li X. Risk factors for bacterial vaginosis: results from a cross-sectional study having a sample of 53,652 women. European Journal Clinical Microbiology and Infectious Diseases. 2014; 33: 1525-1532.

Marconi C, Duarte MT, Silva DC, Silva MG. Prevalence and risk factors for bacterial vaginosis among women of reproductive age attending cervical screening in southeastern. Brazilian International Journal of Gynecology and Obstetrics. 2015; 131: 137-141.

Schwebke JR. Desmond R. Risk factors for bacterial vaginosis in women at high risk for sexually transmitted diseases. Journal of Sexually Transmitted Diseases. 2005; 32: 654-658.

Berg RC, Underland V, Odgaard-Jensen J, Fretheim A, Visit GE. Effects of female genital cutting on physical health outcomes: a systematic review and meta-analysis. British Medical Journal Open Access. 2014; 4(11): 1-12.

Goldenberg RL, Hauth JC, Andrews WW. Intrauterine infection and preterm delivery. N. Engl. J. Med. 2000; 342: 1500–1507.

Hiller SL, Nugent RP, Eschenbach DA, Krohn MA, Gibbs RS, Martin DH, Cotch MF, Edelman R, Pastorek JG. 2nd z Rao AV. Association between Bacterial Vaginosis and Preterm Delivery of a low-birth-weight Infant: the vaginal infection and prematurity study group. New England Journal of Medicine. 1995; 333(26): 1737-1742.

Hillier SL. The vaginal microbial ecosystem and resistance to HIV. AIDS Res. Hum. Retrovir. 1998; 14(Suppl. 1): S17–S21.

Atashili J, Poole C, Ndumbe PM, Adimora AA, Smith JS. Bacterial Vaginosis and HIV acquisition: a meta-analysis of published studies. AIDs. 2008; 22(12): 1493-1498.

Klebanoff SJ, Coombs RW. Viricidal effect of Lactobacillus acidophilus on human immunodeficiency virus type 1: possible role in heterosexual transmission. J. Exp. Med. 1991; 174: 289–292.

Oduyebo OO, Anorlu RI, Ogunsola FT. The effects of antimicrobial therapy on bacterial vaginosis in non-pregnant women. Cochrane Database System revised. 2008; 3: CD006055.

Donder GG, Zodzika J, Rezeberga D. Treatment of Bacterial Vaginosis: What we have and what we miss. Expert Opinion on Pharmacotherapy. 2014; 15: 645-657.

Brashaw CS, Morton AN, Hocking J, Garland SM, Morris MB. High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence. Journal of Infectious Diseases. 2006; 193: 1478-1786.

Hutchison KB, Kip KE, Ness RB. Vaginal douching and development of bacterial vaginosis among women with normal and abnormal vaginal microflora. Journal of Sexually Transmitted Diseases. 2007; 34: 671-675.

Ejike CE, Agbakoba NR, Ezeanya CC, Anukam KC. Health. Social and Economic burden of Bacterial Vaginosis (BV) among the Nigerian women of child bearing age: Can probiotics restore the vaginal dysbiosis? Journal of Medical Laboratory Science. 2019; 29(2): 37-48.

Payne S, Cromer P, Stanek M. Palmer A. Evidence of African-American women’s frustrations with chronic recurrent bacterial vaginosis. Journal of American Academics and Nursing Practice. 2010; 22: 101-108.

Abdullateef RM, Ijaiya MA, Abayomi F, Adeniran AS, Idris H. Bacterial Vaginosis: Prevalence and associated risk factors among non-pregnant women of reproductive age attending a Nigerian tertiary hospital. Malawi Medical Journal. 2017; 29 (4): 290-293.

Ibrahim SM, Bukar M, Galadima GB, Audu BM, Ibrahim HA. Prevalence of Bacterial Vaginosis in pregnant women in Maiduguri, North-Eastern, Nigeria. Nigeria Journal of Clinical Practice. 2014; 17(2): 154-158.

Wariso KT, Igunma JA, Oboro IL, Olonipili FA, Robinson N. Prevalence of Bacterial Vaginosis among patients with Vulvovaginitis in a Tertiary Hospital in Port Harcourt, River State, Nigeria. Asian Journal of Medicine and Health. 2017; 7(4): 1-7.

Baustista CT, Wurapa E, Warren B, Morris S, Hollingsworth B, Sanchez SL. Bacterial Vaginosis: A synthesis of the literature on aetiology, prevalence, risk factors and relationship with Chlamydia and Gonorrhea infections. Journal of Military Medical Research. 2016; 3: 4.

Van De Wijgert JHHM, Mason PR, Gwanzura L, Mbizvo MT, Chirenje ZM, Iliff V, Shiboski S, Padian NS. Intravaginal practices, Vaginal flora disturbances and Acquisition of Sexually Transmitted Diseases. Journal of Infectious Diseases. 2000; 181(2): 587-594.

Akomoneh E, Foche F, Ajonins MU. Prevalence of BV among sexually active women attending CDC central clinic Tiko, South West Region, Cameroon. African Journal of Infectious Diseases. 2016; 10(2): 96-101.

Muvunyi CM, Hernandez CT. Prevalence of BV in women with vaginal symptoms in south province of Rwanda. African Journal of Clinical and Experimental Microbiology. 2009; 10(3): 156-163.

Okoli AC, Agbakoba NR, Ezaeanya CC, Oguejiofor CB, Anukam KC. Comparative abundance and functional biomarkers of the vagina and gut microbiome of Nigerian women with Bacterial Vaginosis: A study with 16S rRNA metagenomics. Journal of Medical Laboratory Science. 2019; 29(1): 1-26.

Karasz A, Anderson M. The vagina monologues: women’s experiences of vaginal complaints in a primary care setting. Journal of Social Science and Medicine. 2003; 56: 1013-1021.